A Nonhuman Primate Model for Preclinical Testing of New Tuberculosis Vaccines

Nonhuman primates appear to have significant advantages over conventional laboratory animals in terms of modeling pulmonary tuberculosis for purposes of vaccine evaluation. Primates are quite susceptible to infection by the aerosol route, develop a humanlike disease, exhibit antigen-induced T lympho...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2000-06, Vol.30 (Supplement-3), p.S210-S212
Main Author: McMurray, David N.
Format: Article
Language:English
Subjects:
Aerosols
Animal models
Animals
Bacterial diseases
BCG Vaccine
Biological and medical sciences
Disease Models, Animal
Experimental bacterial diseases and models
Haplorhini
Humans
Immunology
Infections
Infectious diseases
Medical sciences
Monkeys
Mycobacterium tuberculosis
Mycobacterium tuberculosis - growth & development
Primates
Tuberculosis
Tuberculosis vaccine
Tuberculosis, Pulmonary - immunology
Tuberculosis, Pulmonary - prevention & control
Vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nonhuman primates appear to have significant advantages over conventional laboratory animals in terms of modeling pulmonary tuberculosis for purposes of vaccine evaluation. Primates are quite susceptible to infection by the aerosol route, develop a humanlike disease, exhibit antigen-induced T lymphocyte reactivity both in vitro and in vivo, and can be protected quite effectively by bacille Calmette-Guérin vaccination. There are fewer than a dozen published studies of experimental tuberculosis in primates, and all of the available data on the response of primates to vaccination have been generated in rhesus monkeys (Macaca mulatta). There have been no modern immunologic studies of primate tuberculosis. Thus, responses to tuberculosis vaccines in primates are only minimally characterized, and much additional baseline work remains to be done before the responses to new vaccines can be placed in the proper biological context.
ISSN:1058-4838
1537-6591
DOI:10.1086/313885